Quality of Life and Economic Repercussions of Combining Proactive Medication Assessment and Electronic Monitoring of Toxicities in Subjects Undergoing Oral Cancer Therapy

NARecruitingINTERVENTIONAL
Enrollment

196

Participants

Timeline

Start Date

September 16, 2022

Primary Completion Date

October 31, 2025

Study Completion Date

October 31, 2026

Conditions
Cancer
Interventions
OTHER

THESS monitoring

Consultation with the pharmacist to look for possible medication interactions between the oral therapy and the patient's usual treatments and to inform the patient about his treatment to improve QOL and compliance. Consultation and follow-up by a nurse. Weekly notification by THESS Application of the symptoms experienced by the patient over the last 7 days

Trial Locations (6)

19100

RECRUITING

Centre Hospitalier Dubois Brive, Brive-la-Gaillarde

69100

RECRUITING

Médipôle Lyon-Villeurbanne, Villeurbanne

81108

RECRUITING

Chic Castres-Mazamet, Castres

43 012

RECRUITING

Centre Hospitalier Emile ROUX, Le Puy-en-Velay

Unknown

RECRUITING

CHU de Nîmes, Nîmes

RECRUITING

Institut cancerologie du Gard, Nîmes

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Nīmes

OTHER